D.E. Shaw & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,000
Closed -$1.15M 4713
2025
Q2
$1.15M Hold
3,000
﹤0.01% 3135
2025
Q1
$1.04M Buy
3,000
+100
+3% +$32.2K ﹤0.01% 3064
2024
Q4
$870K Buy
+2,900
New +$1.01M ﹤0.01% 3279
2021
Q1
Sell
-10,800
Closed -$1.78M 4231
2020
Q4
$1.78M Buy
10,800
+800
+8% +$117K ﹤0.01% 2632
2020
Q3
$1.25M Sell
10,000
-24,100
-71% -$2.98M ﹤0.01% 2716
2020
Q2
$3.31M Buy
34,100
+30,000
+732% +$3.12M ﹤0.01% 2001
2020
Q1
$368K Buy
4,100
+1,800
+78% +$233K ﹤0.01% 3365
2019
Q4
$340K Sell
2,300
-3,500
-60% -$470K ﹤0.01% 3579
2019
Q3
$698K Sell
5,800
-5,200
-47% -$672K ﹤0.01% 3043
2019
Q2
$1.49M Sell
11,000
-4,000
-27% -$506K ﹤0.01% 2443
2019
Q1
$1.96M Hold
15,000
﹤0.01% 2174
2018
Q4
$1.87M Buy
15,000
+13,500
+900% +$1.81M ﹤0.01% 2215
2018
Q3
$209K Buy
+1,500
New +$187K ﹤0.01% 3527
2016
Q4
Sell
-10,000
Closed -$756K 3498
2016
Q3
$756K Hold
10,000
﹤0.01% 2570
2016
Q2
$770K Hold
10,000
﹤0.01% 2562
2016
Q1
$781K Sell
10,000
-70,000
-88% -$4.89M ﹤0.01% 2522
2015
Q4
$5.41M Hold
80,000
0.01% 1351
2015
Q3
$6.19M Buy
80,000
+40,000
+100% +$3.54M 0.01% 1245
2015
Q2
$3.63M Buy
40,000
+10,000
+33% +$801K 0.01% 1725
2015
Q1
$2.26M Sell
30,000
-44,300
-60% -$3.18M ﹤0.01% 1912
2014
Q4
$5.45M Hold
74,300
0.01% 1503
2014
Q3
$5.24M Buy
74,300
+50,000
+206% +$3.3M 0.01% 1535
2014
Q2
$1.37M Hold
24,300
﹤0.01% 2644
2014
Q1
$1.28M Hold
24,300
﹤0.01% 2814
2013
Q4
$1.16M Buy
+24,300
New +$1.12M ﹤0.01% 3035

Other funds holding HCA

D.E. Shaw & Co's HCA Position: Q1 2026 in Review

D.E. Shaw & Co increased its HCA Healthcare (HCA) stake by 11% in Q1 2026, buying an estimated $2.42M and bringing the position to 49,935 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #1044.

D.E. Shaw & Co first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $235M in Q3 2015. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • D.E. Shaw & Co held 49,935 shares of HCA Healthcare worth $23.6M as of Q1 2026.
  • D.E. Shaw & Co bought 4,816 HCA Healthcare shares in Q1 2026, an estimated $2.42M.
  • HCA Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1044 holding.
  • D.E. Shaw & Co first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
  • D.E. Shaw & Co's HCA Healthcare position peaked at $235M in Q3 2015.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.